Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PLG
12126
PUT
Platinum Group Metals
PLG
$188M
| $18.7K | ﹤0.01% |
15,100
+5,100
| +51% | +$6.55K |
|
12127
PUT
Nektar Therapeutics
NKTR
$2.56B
| $18.7K | ﹤0.01% |
+1,833
| New | +$23.9K |
|
12128
Calidi Biotherapeutics
CLDI
$3.77M
| $18.5K | ﹤0.01% |
170
+50
| +42% | +$9.12K |
|
12129
CytomX Therapeutics
CTMX
$730M
| $18.3K | ﹤0.01% |
28,734
-31,044
| -52% | -$24.1K |
|
|
SOL
12130
DELISTED
Emeren Group
SOL
| $18.2K | ﹤0.01% |
11,561
-73,047
| -86% | -$128K |
|
12131
PUT
Sypris Solutions
SYPR
$49.5M
| $18K | ﹤0.01% |
+11,200
| New | +$21.8K |
|
|
KYNB
12132
Kyntra Bio
KYNB
$28.9M
| $18K | ﹤0.01% |
2,327
-3,041
| -57% | -$36.5K |
|
12133
Artelo Biosciences
ARTL
$2.71M
| $17.8K | ﹤0.01% |
+1,133
| New | +$22.8K |
|
12134
AYTU BioPharma
AYTU
$24.7M
| $17.8K | ﹤0.01% |
+14,865
| New | +$21.6K |
|
12135
Q32 Bio
QTTB
$457M
| $17.8K | ﹤0.01% |
+10,810
| New | +$29.1K |
|
12136
PUT
FingerMotion
FNGR
$16.7M
| $17.8K | ﹤0.01% |
13,000
-142,100
| -92% | -$183K |
|
|
TMQ
12137
Trilogy Metals
TMQ
$655M
| $17.8K | ﹤0.01% |
+11,469
| New | +$15.8K |
|
|
ELEV
12138
DELISTED
Elevation Oncology
ELEV
| $17.7K | ﹤0.01% |
68,437
+30,512
| +80% | +$17.4K |
|
|
HOFV
12139
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
| $17.7K | ﹤0.01% |
+21,287
| New | +$22.9K |
|
12140
CALL
Passage Bio
PASG
$14.8M
| $17.6K | ﹤0.01% |
2,515
+1,990
| +379% | +$21.5K |
|
12141
Network-1 Technologies
NTIP
$35.4M
| $17.6K | ﹤0.01% |
13,519
+1,218
| +10% | +$1.67K |
|
|
CRESW
12142
DELISTED
Cresud SACIF y A. Warrant
CRESW
| $17.5K | ﹤0.01% |
+21,046
| New | +$20.4K |
|
12143
Performance Shipping
PSHG
$21.5M
| $17.4K | ﹤0.01% |
+10,830
| New | +$17.9K |
|
12144
PUT
Seres Therapeutics
MCRB
$45.1M
| $17.4K | ﹤0.01% |
1,245
-5,265
| -81% | -$82.4K |
|
|
SBDS
12145
DELISTED
Solo Brands Inc
SBDS
| $17.4K | ﹤0.01% |
2,595
+1,623
| +167% | +$49.7K |
|
|
UBX
12146
CALL
DELISTED
Unity Biotechnology
UBX
| $17.4K | ﹤0.01% |
+16,700
| New | +$30.2K |
|
|
PCTTW
12147
PureCycle Technologies Inc Warrant
PCTTW
| $17.3K | ﹤0.01% |
+11,191
| New | +$31.1K |
|
12148
Lulu's Fashion Lounge
LVLU
$44.3M
| $17.3K | ﹤0.01% |
2,890
+159
| +6% | +$1.79K |
|
12149
CALL
NanoViricides
NNVC
$34.4M
| $17.3K | ﹤0.01% |
+14,800
| New | +$18.8K |
|
12150
CALL
Actinium Pharmaceuticals
ATNM
$30.1M
| $17.2K | ﹤0.01% |
10,700
-3,700
| -26% | -$4.7K |
|
Similar funds
Susquehanna International Group's Q1 2025 Portfolio in Review
As of Q1 2025, Susquehanna International Group held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Susquehanna International Group withdrew a net $24.4B in Q1 2025, closing 1,483 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Susquehanna International Group opened a new position in Brookfield Asset Management worth $86M.
- Susquehanna International Group's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Susquehanna International Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Susquehanna International Group's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Susquehanna International Group fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Susquehanna International Group's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Susquehanna International Group opened 1,775 new positions and closed 1,483 in Q1 2025.
- Susquehanna International Group's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.